6.5 | Responsible Industry Practices
Public Industry Exchange
Public Industry Exchange
Active 3 months ago
Purpose:
To provide a neutral accountability space where all industry participants — vendors, platforms,... View more
Public Industry Exchange
Organizer:
- Organized by
-
-
Group Description
Purpose:
To provide a neutral accountability space where all industry participants — vendors, platforms, implementers, medtech, pharma, and device innovators — discuss responsible, transparent, and ethical AI practices in healthcare.
Description:
Unlike other groups that focus on specific industry segments, this one is for shared challenges and values:Ethical AI development (bias, fairness, explainability).Compliance & regulatory readiness (EU AI Act, MDR/IVDR, FDA).Post-market surveillance and monitoring (how companies track AI after launch).Partnership frameworks (industry–hospital–academia collaborations).It’s where industry voices meet clinicians, researchers, regulators, and patients to align on trust and responsibility.
Intended Use:
Share frameworks for responsible AI practices.Discuss regulatory compliance models.Provide real-world lessons on post-deployment monitoring.Collaborate on cross-sector partnerships that strengthen trust.
Limitations:
Not a marketing zone — companies cannot use “responsibility” language to mask product promotion.No lobbying — policy discussions must remain evidence-based.Confidential compliance materials cannot be disclosed.Must stay principle-driven, not company-driven.
Key Activities:
Posting responsibility pledges or lessons (“How we structured bias monitoring for an imaging AI tool”).Hosting cross-role workshops (clinicians + vendors + regulators).Sharing case insights on transparency (anonymized performance reports).Discussing compliance obligations under MDR/IVDR and EU AI Act.
Potential Users:
AI vendors (6.1) wanting to showcase their responsible practices.Platform providers (6.2) discussing compliance across multiple vendors.Implementation partners (6.3) helping hospitals meet regulatory duties.MedTech & Pharma innovators (6.4) embedding ethics in devices and trials.Clinicians, researchers, policy experts providing oversight and feedback.Patient advocates ensuring transparency and accountability.
Possible Discussions:
“How should vendors disclose AI limitations to hospitals?”.“What post-market monitoring obligations apply under the EU AI Act?”.“Best practices for explainability in clinical AI tools.”.“How to design multi-stakeholder governance boards for AI oversight.”.“Should vendors share performance dashboards with hospital partners?”
Other Important Notes:
This group strengthens AIiHC’s identity as a neutral nonprofit — ensuring vendors don’t just talk about products, but also about responsibility.It connects directly to Pillar 3 (Foundational Principles), especially Ethical AI, Data Governance, and Regulation.Moderators may invite companies to sign a Community Responsibility Pledge before contributing here.Over time, this subgroup could produce shared guidelines, templates, or even a community “Responsible AI Charter.”
